Sendai, Japan

Mikio Kikuchi

This inventor holds 2 USPTO granted patents. Top assignees: Kayaku Antibiotic Research Co., Ltd., Other. Active years: 1976-1977.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Sendai, JA (1976)
  • Osaka, JA (1977)

Company Filing History:


Years Active: 1976-1977

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mikio Kikuchi: Innovator in Antibiotic Research

Introduction

Mikio Kikuchi is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of antibiotic research, holding 2 patents that focus on innovative therapeutic compositions. His work has the potential to impact the treatment of various infections.

Latest Patents

Kikuchi's latest patents include a groundbreaking antibiotic known as TS-0822. This antibiotic serves as both a prophylactic and therapeutic composition effective in the treatment of coccidiomycosis. Additionally, he has developed a composition containing double-stranded RNA extracted from basidiomycetes. This composition acts as an inducer of interferon for viral infections, primarily composed of double-stranded RNA isolated from the spores or mycelium of natural or cultivated basidiomycetes, such as Cortinellus Shiitake.

Career Highlights

Throughout his career, Kikuchi has worked with Kayaku Antibiotic Research Co., Ltd., where he has contributed to the advancement of antibiotic research. His innovative approaches have positioned him as a key figure in the development of new therapeutic options.

Collaborations

Kikuchi has collaborated with notable individuals in the field, including Nakao Ishida and Fumio Kitame. These partnerships have further enhanced his research and development efforts.

Conclusion

Mikio Kikuchi's contributions to antibiotic research and his innovative patents highlight his importance in the field. His work continues to pave the way for new treatments and advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…